RULE NO: RULE TITLE
64K-1.001: Patient Advisory Alerts and Reports
64K-1.002: American Society of Automation in Pharmacy Standards and Formats
64K-1.003: Accessing Database
64K-1.004: Management and Operation of Database
64K-1.005: Storage and Security of Information
64K-1.006: Program Evaluation and Other
PURPOSE AND EFFECT: To encourage responsible prescribing by implementing provisions to help establish a limited access comprehensive electronic database system for controlled substances.
SUBJECT AREA TO BE ADDRESSED: Prescription Drug Monitoring Program
SPECIFIC AUTHORITY: 499.05, 893.055 FS.
LAW IMPLEMENTED: 893.055, 893.0551 FS.
A RULE DEVELOPMENT WORKSHOP WILL BE HELD AT THE DATE, TIME AND PLACE SHOWN BELOW:
DATE AND TIME: Wednesday, March 31, 2010, 9:30 a.m. – 1:00 p.m.
PLACE: The Betty Easley Conference Center, Conference Room #152, 4075 Esplanade Way, Tallahassee, Florida 32399
Pursuant to the provisions of the Americans with Disabilities Act, any person requiring special accommodations to participate in this workshop/meeting is asked to advise the agency at least five (5) days before the workshop/meeting by contacting: Shirleen Gee, Department of Health, Office of the General Counsel, at (850)245-4005 or email address Shirleen_Gee@doh.state.fl.us. If you are hearing or speech impaired, please contact the agency using the Florida Relay Service, 1(800)955-8771 (TDD) or 1(800)955-8770 (Voice).
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Diane Orcutt, Deputy Division Director, 4052 Bald Cypress Way, Bin #C75, Tallahassee, FL 32399-3275 or email address: Diane_Orcutt@doh.state.fl.us

THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS NOT AVAILABLE.